EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL

Matteson E, Kelly C, Distler J, Hoffmann-Vold AM, Seibold J, Mittoo S, Distler O, Dellaripa PF, James A, Schlenker-Herceg R, Stowasser S, Quaresma M, Flaherty KR (2020)


Publication Type: Conference contribution

Publication year: 2020

Journal

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 76-76

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

Event location: , ELECTR NETWORK

DOI: 10.1136/annrheumdis-2020-eular.3211

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Matteson, E., Kelly, C., Distler, J., Hoffmann-Vold, A.M., Seibold, J., Mittoo, S.,... Flaherty, K.R. (2020). EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 76-76). , ELECTR NETWORK: LONDON: BMJ PUBLISHING GROUP.

MLA:

Matteson, E., et al. "EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL." Proceedings of the Annual European Congress of Rheumatology (EULAR), , ELECTR NETWORK LONDON: BMJ PUBLISHING GROUP, 2020. 76-76.

BibTeX: Download